arrow
B

Brian F. Kiesel

university of pittsburgh
H指数:19
被引数:1,216

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

I期研究:berzosertib(M6620,VX-970)联合顺铂和放疗治疗局部晚期头颈鳞状细胞癌患者(ETCTN 9950)

Cancer
IF5.1
2026-03-150
OAAI
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

Alnuctamab,一种靶向B细胞成熟抗原的双价T细胞结合剂,用于复发或难治性多发性骨髓瘤患者:一项1期首次人体研究的成果

Leukemia
IF13.4
2026-01-070
OAAI
Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiation

ATR抑制剂的体内比较毒理学研究:ceralasertib、elimusertib和berzosertib单药及与电离辐射联合使用的比较

2025-07-010
PRE
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)
2023-02-280
OA
A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

belinostat在晚期癌症和不同程度肝功能障碍患者中的I期药代动力学研究

2019-09-0414
OAAI